Assessment of Vitronectin, Soluble Epithelial-Cadherin and TGF-β1 as a Serum Biomarker With Predictive Value for Endometrial and Ovarian Cancers

Turkish Journal of Pharmaceutical Sciences - Turkey
doi 10.4274/tjps.81994
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Galenos Yayinevi

Related search

Soluble Neural-Cadherin as a Novel Biomarker for Malignant Bone and Soft Tissue Tumors

BMC Cancer
Cancer ResearchOncologyGenetics
2013English

TGF-β1 and IL-10 Expression in Epithelial Ovarian Cancer Cell Line A2780

Tropical Journal of Pharmaceutical Research
PharmacologyPharmaceutical Science
2016English

KPNA2 Is a Potential Diagnostic Serum Biomarker for Epithelial Ovarian Cancer and Correlates With Poor Prognosis

Tumor Biology
MedicineCancer Research
2017English

Synchronous Primary Endometrial and Ovarian Cancers: A Critical Update

International Journal of Gynecology & Clinical Practices
2015English

The Prognostic Value of Morphometry in Advanced Epithelial Ovarian Cancers

British Journal of Cancer
Cancer ResearchOncology
1995English

Estrogen Receptor-Alpha as a Predictive Biomarker in Endometrioid Endometrial Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2016English

Preclinical Studies on Histone Deacetylase Inhibitors as Therapeutic Reagents for Endometrial and Ovarian Cancers

Future Oncology
MedicineCancer ResearchOncology
2011English

Serum Activin B Levels as Predictive Biomarker for Ectopic Pregnancy

Canadian Journal of Biotechnology
2017English

The Potential Predictive Value of Serum srCaS1 Levels for Overall Survival in Endometrial Cancer

Ginekologia Polska
GynecologyObstetrics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy